MARKET

EXEL

EXEL

Exelixis
NASDAQ

Real-time Quotes | Nasdaq Last Sale

17.18
+0.66
+3.98%
Opening 11:49 04/06 EDT
OPEN
16.99
PREV CLOSE
16.52
HIGH
17.37
LOW
16.77
VOLUME
795.64K
TURNOVER
--
52 WEEK HIGH
24.59
52 WEEK LOW
13.67
MARKET CAP
5.25B
P/E (TTM)
16.86
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average EXEL stock price target is 24.46 with a high estimate of 35.00 and a low estimate of 19.00.

EPS

EXEL News

More
  • Coronavirus Roundtable - Strains And Hopes In The Healthcare Sector
  • Seeking Alpha - Article · 2d ago
  • 3 Top Stocks That Will Make You Richer in Q2 (and Beyond)
  • MotleyFool.com · 4d ago
  • XBI: Biotech ETF Expected To Outperform During And After The Coronavirus Pandemic
  • Seeking Alpha - Article · 6d ago
  • 3 Covid-19 Proof Biotech Stocks
  • Seeking Alpha - Article · 03/30 08:27

Industry

Biotechnology & Medical Research
+3.90%
Pharmaceuticals & Medical Research
+3.20%

Hot Stocks

Symbol
Price
%Change

About EXEL

Exelixis, Inc. is a biopharmaceutical company. The Company is focused on discovery, development and commercialization of new medicines to manage care and outcomes for people with cancer. The Company's cabozantinib product is an inhibitor of multiple tyrosine kinases, including MET, AXL, and VEGF receptors. The Company's CABOMETYX tablets are approved for previously treated advanced kidney cancer and COMETRIQ capsules are approved for progressive, metastatic medullary thyroid cancer. The third product, Cotellic, is a formulation of cobimetinib, a selective inhibitor of MEK is approved as part of a combination regimen to treat advanced melanoma. Both cabozantinib and cobimetinib have shown potential in a range of forms of cancer and are the subjects of broad clinical development programs. The Company's XL888 is a small molecule oral inhibitor of Heat Shock Protein 90 (HSP90), a molecular chaperone protein.
More

Webull offers kinds of Exelixis, Inc. stock information, including NASDAQ:EXEL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EXEL stock news, and many more online research tools to help you make informed decisions.